|
Study of Decision Making in Patients Participating in Phase I Clinical Trials Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about Study of Decision Making in Patients Participating in Phase I Clinical Trials conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Study of Decision Making in Patients Participating in Phase I Clinical Trials Clinical research trials and Study of Decision Making in Patients Participating in Phase I Clinical Trials medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as Study of Decision Making in Patients Participating in Phase I Clinical Trials. Study of Decision Making in Patients Participating in Phase I Clinical Trials Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Study of Decision Making in Patients Participating in Phase I Clinical Trials clinical trial. Subjects often receive the most expert healthcare possible for their Study of Decision Making in Patients Participating in Phase I Clinical Trials condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Study of Decision Making in Patients Participating in Phase I Clinical Trials Study of Decision Making in Patients Participating in Phase I Clinical Trials
Study of Decision Making in Patients Participating in Phase I Clinical Trials
For Condition: psychosocial effects/treatment,unspecified adult solid tumor, protocol specific
Status: Recruiting
Sponsor(s): National Cancer Institute (NCI) ,
Synopsis: RATIONALE: Studying individuals who are enrolled in phase Iclinical trials may help to improve the way in which clinical trials are conducted. PURPOSE: Clinical trial to study patients' personality traits, reasons for participating in the trial, and understanding of their medical situation, prognosis, and risks and benefits of participating in a phase I trial.
Details: OBJECTIVES: - Determine the range of personality traits of patients enrolled in a phase I clinical trial. - Determine these patients' understanding of their medical situation and prognosis. - Determine these patients' understanding of risks and benefits of phase I clinical trials. - Determine these patients' reasons for participating in a phase I clinical trial. - Determine the risk/benefit trade-offs of these patients. - Determine the existential outlook of these patients. - Determine the information gathering nature of these patients. OUTLINE: This is a multicenter study. Before beginning phase I clinical trial treatment, patients complete a survey over 30-45 minutes administered by an interviewer. Patients then self-administer the Temperament and Character Inventory assessment over 30 minutes. PROJECTED ACCRUAL: Approximately 250 patients will be accrued for this study within 6 months.
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: DISEASE CHARACTERISTICS: - Consented to enrollment in a phase I cancer clinical trial PATIENT CHARACTERISTICS: Age - 18 and over Performance status - Not specified Life expectancy - Not specified Hematopoietic - Not specified Hepatic - Not specified Renal - Not specified Other - Understands written English PRIOR CONCURRENT THERAPY: Biologic therapy - Not specified Chemotherapy - Not specified Endocrine therapy - Not specified Radiotherapy - Not specified Surgery - Not specified Other - No concurrent enrollment in other clinical trials evaluating phase I patient attitudes
Total Enrollment:
Location and Contact Information:
Overall Study Official:
ManishAgrawal, Study Chair, National Cancer Institute (NCI)
University of Texas - MD Anderson Cancer Center *Recruiting*
Houston, Texas, 77030-4009
United States
Recruiting Marty Smith 713-792-3204
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Contact Person Not Available
Cancer Therapy and Research Center *Recruiting*
San Antonio, Texas, 78229
United States
Recruiting Eric Rowinsky 210-616-5945
Fox Chase Cancer Center *Recruiting*
Philadelphia, Pennsylvania, 19111
United States
Recruiting Neal Meropol 215-728-2450
Robert H. Lurie Comprehensive Cancer Center at Northwestern University *Recruiting*
Chicago, Illinois, 60611-3013
United States
Recruiting Jamie Von Roenn 312-908-5250
Additional Information:
Study ID Numbers: CDR0000269911; NCI-03-C-0063
Study Start Date:
Record last reviewed: January 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00054223
Other Unspecified Adult Solid Tumor, Protocol Specific Studies:
1. Study of Decision Making in Patients Participating in Phase I Clinical Trials
2. Stress Reduction in Older Women With Stage II, Stage III, or Stage IV Breast Cancer
3. Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia
4. Video Support Program For Families With a Parent Newly Diagnosed With Cancer
5. Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung Cancer
Related Studies:
Other unspecified adult solid tumor, protocol specific Clinical Trials
Other Texas Clinical Trials
Other San Antonio Clinical Trials
Study of Decision Making in Patients Participating in Phase I Clinical Trials
|
|
|
|
|
|
|
|